About Jersey Shore Cancer Center at Jersey Shore University Medical Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gynecologic Oncology Group
2
SWOG Cancer Research Network
2
Alliance for Clinical Trials in Oncology
1
Eastern Cooperative Oncology Group
1
Fox Chase Cancer Center
1
Rutgers, The State University of New Jersey
1
University of Medicine and Dentistry of New Jersey
1
Clinical Trials at Jersey Shore Cancer Center at Jersey Shore University Medical Center
During the past decade, Jersey Shore Cancer Center at Jersey Shore University Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671
Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
2001-09-01
2001-09-01
Withdrawn
0
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
2005-05-01
Completed
55
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
2005-01-01
Completed
81
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer
2005-09-01
2010-10-01
Completed
44
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
2005-10-01
2011-03-01
Completed
2,697
Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
2006-05-01
2016-06-20
Terminated
49
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" #1 sponsor was "Gynecologic Oncology Group" with 2 trials, followed by "SWOG Cancer Research Network" with 2 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "Fox Chase Cancer Center"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jersey Shore Cancer Center at Jersey Shore University Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "North Central Cancer Treatment Group" with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Rutgers Cancer Institute of New Jersey" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Jersey Shore Cancer Center at Jersey Shore University Medical Center
According to Clinical.Site data, the most researched conditions in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" are
"Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Breast Adenocarcinoma" (1 trials), "Cancer Survivor" (1 trials) and "Cognitive/Functional Effects" (1 trials). Many other conditions were trialed in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Jersey Shore Cancer Center at Jersey Shore University Medical Center
Most popular intervention types in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" are "Drug" (8 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "gemcitabine hydrochloride" (3 trials), "carboplatin" (2 trials), "imatinib mesylate" (2 trials), "paclitaxel" (2 trials) and "atrasentan hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Jersey Shore Cancer Center at Jersey Shore University Medical Center
The vast majority of trials in "Jersey Shore Cancer Center at Jersey Shore University Medical Center" are
5 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Jersey Shore Cancer Center at Jersey Shore University Medical Center
Currently, there are NaN active trials in "Jersey Shore Cancer Center at Jersey Shore University Medical Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Jersey Shore Cancer Center at Jersey Shore University Medical Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Jersey Shore Cancer Center at Jersey Shore University Medical Center, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".